392766

AD-Mix-β

• Synonym(e): AD-mix-beta
• MDL-Nummer: MFCD00198107
• UNSPSC-Code: 12352005
• PubChem Substanz-ID: 329755836
• NACRES: NA.22

Eigenschaften

• Form: powder
• Qualitätsniveau: 100
• SMILES String: CC[C@@H]1CN2CCC1CC2[C@H](Oc3nnc(O[C@@H](C4CC5CCN4C[C@@H]5CC)c6ccnc7ccc(OC)cc67)c8ccccc38)c9ccnc%10ccc(OC)cc9%10
• InChI: 1S/C48H54N6O4/c1-5-29-27-53-21-17-31(29)23-43(53)45(35-15-19-49-41-13-11-33(55-3)25-39(35)41)57-47-37-9-7-8-10-38(37)48(52-51-47)58-46(44-24-32-18-22-54(44)28-30(32)6-2)36-16-20-50-42-14-12-34(56-4)26-40(36)42/h7-16,19-20,25-26,29-32,43-46H,5-6,17-18,21-24,27-28H2,1-4H3/t29-,30-,31-,32-,43+,44+,45-,46-/m0/s1
• InChIKey: YUCBLVFHJWOYDN-HVLQGHBFSA-N

Beschreibung

Allgemeine Beschreibung

Contains chiral ligand (DHQD)₂PHAL

Anwendung

Reagent for Sharpless Asymmetric Dihydroxylation.

Catalyst employed in the Sharpless Asymmetric Dihyroxylation of (E,E)- or (E,Z)-1,3-dienoates. Also used in the preparation of ß-hydroxy-γ-lactones from ß,γ-unsaturated esters.

Komponenten

Mixture contains:
(DHQD)₂PHAL (Cat. No. 392731) 0.0016 mole
Potassium carbonate, powder0.4988 mole
Potassium ferricyanide0.4988 mole
Potassium osmate dihydrate0.0007 mole

Rechtliche Hinweise

Sold under license from Rhodia Pharma Solutions.

Sicherheitshinweise

• Piktogramme: GHS07,GHS09
• Signalwort: Warning
• H-Sätze: H315,H319,H335,H411
• P-Sätze: P261 - P264 - P271 - P273 - P302 + P352 - P305 + P351 + P338
• Gefahreneinstufungen: Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Zielorgane: Respiratory system
• Zusätzliche Gefahrenhinweise: EUH032
• Lagerklassenschlüssel: 13 - Non Combustible Solids
• WGK: WGK 2
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: dust mask type N95 (US), Eyeshields, Gloves